Manheimer-Lory A, Irigoyen M, Gaynor B, Monhian R, Splaver A, Diamond B
Department of Microbiology and Immunology, Albert Einstein College Medicine, Yeshiva University, Bronx, New York 10461-1602, USA.
Ann N Y Acad Sci. 1995 Sep 29;764:301-11.
Our previous studies of anti-DNA antibodies in SLE have demonstrated a preferential use of V kappa I and V lambda II gene families to encode light chains of antibodies that express the anti-DNA-associated 3I and 8.12 idiotypes, respectively. In this study, we employed PCR to obtain V kappa I and V lambda II germline genes from lupus patients in order to compare the germline genes to genes encoding expressed V kappa I and V lambda II light chains and to analyze the extent of somatic mutation among autoantibodies that derive from these light chain families. Our analysis shows that the germline repertoire among all persons (autoimmune and healthy) is comparable and that somatic mutation is used to diversify autoantibodies as well as anti-microbial antibodies. We have observed that autoantibodies encoded by V kappa I and V lambda II genes have a higher number of amino acid replacements in CDRs than autoantibodies encoded by other VL gene families. In addition, there may be subtle differences in V gene usage that distinguish the V kappa I-encoded light chains from other expressed V kappa light chains.
我们之前对系统性红斑狼疮(SLE)中抗DNA抗体的研究表明,VκI和VλII基因家族在编码抗体轻链时具有偏好性,这些抗体分别表达与抗DNA相关的3I和8.12独特型。在本研究中,我们采用聚合酶链反应(PCR)从狼疮患者中获取VκI和VλII种系基因,以便将种系基因与编码已表达的VκI和VλII轻链的基因进行比较,并分析源自这些轻链家族的自身抗体中体细胞突变的程度。我们的分析表明,所有人群(自身免疫患者和健康人)的种系库具有可比性,并且体细胞突变用于使自身抗体以及抗微生物抗体多样化。我们观察到,由VκI和VλII基因编码的自身抗体在互补决定区(CDR)中的氨基酸替换数量比由其他VL基因家族编码的自身抗体更多。此外,在V基因使用方面可能存在细微差异,这使得VκI编码的轻链与其他已表达的Vκ轻链有所区别。